NO20051601L - Kombinasjonsterapi med gemcitabin og zd6126 - Google Patents
Kombinasjonsterapi med gemcitabin og zd6126Info
- Publication number
- NO20051601L NO20051601L NO20051601A NO20051601A NO20051601L NO 20051601 L NO20051601 L NO 20051601L NO 20051601 A NO20051601 A NO 20051601A NO 20051601 A NO20051601 A NO 20051601A NO 20051601 L NO20051601 L NO 20051601L
- Authority
- NO
- Norway
- Prior art keywords
- gemcitabine
- human
- combination therapy
- warm
- treated
- Prior art date
Links
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 title abstract 6
- 229960005277 gemcitabine Drugs 0.000 title abstract 6
- 238000002648 combination therapy Methods 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 230000000254 damaging effect Effects 0.000 abstract 2
- 230000005855 radiation Effects 0.000 abstract 2
- 230000002792 vascular Effects 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000013066 combination product Substances 0.000 abstract 1
- 229940127555 combination product Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
Abstract
Foreliggende oppfinnelse angår en metode for fremkalling av en ødeleggende effekt på. vaskulatur hos et varmblodig dyr så som et menneske, som eventuelt blir behandlet med ioniserende stråling, spesielt en metode for behandling av kreft, som involverer en fast tumor, som omfatter å administrere ZD6126 i kombinasjon med gemcitabin; et farmasøytisk preparat som omfatter ZD6126 og gemcitabin; et kombinasjonsprodukt som omfatter ZD6126 og gemcitabin, for anvendelse ved en metode for terapeutisk behandling av en menneske- eller dyrekropp; et sett som omfatter ZD6126 og gemcitabin; og anvendelsen av ZD6126 og gemcitabin ved fremstilling av et medikament for anvendelse ved fremkalling av en ødeleggende effekt på vaskulatur hos et varmblodig dyr så som et menneske, som eventuelt blir behandlet med ioniserende stråling.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0223379.9A GB0223379D0 (en) | 2002-10-09 | 2002-10-09 | Combination therapy |
| PCT/GB2003/004328 WO2004032939A1 (en) | 2002-10-09 | 2003-10-06 | Combination therapy with gemcitabine and zd6126 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20051601L true NO20051601L (no) | 2005-04-22 |
Family
ID=9945537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051601A NO20051601L (no) | 2002-10-09 | 2005-03-30 | Kombinasjonsterapi med gemcitabin og zd6126 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20060058260A1 (no) |
| EP (1) | EP1562610B1 (no) |
| JP (1) | JP2006504722A (no) |
| KR (1) | KR20050055758A (no) |
| CN (1) | CN1703225A (no) |
| AT (1) | ATE339209T1 (no) |
| AU (1) | AU2003274306B2 (no) |
| BR (1) | BR0315087A (no) |
| CA (1) | CA2500906A1 (no) |
| DE (1) | DE60308403T2 (no) |
| GB (1) | GB0223379D0 (no) |
| MX (1) | MXPA05003625A (no) |
| NO (1) | NO20051601L (no) |
| WO (1) | WO2004032939A1 (no) |
| ZA (1) | ZA200502759B (no) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9714249D0 (en) * | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| US6537585B1 (en) * | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
| US6291504B1 (en) * | 1999-10-20 | 2001-09-18 | Dupont Pharmaceuticals Company | Acylsemicarbazides and their uses |
| MXPA02009603A (es) * | 2000-03-31 | 2004-05-14 | Angiogene Pharm Ltd | Terapias de dosis divididas con actividad de deterioro vascular. |
| EE200200565A (et) * | 2000-03-31 | 2004-06-15 | Angiogene Pharmaceuticals Ltd. | Vaskulaarse kahjustava toimega kombinatsioonravi |
-
2002
- 2002-10-09 GB GBGB0223379.9A patent/GB0223379D0/en not_active Ceased
-
2003
- 2003-10-06 DE DE60308403T patent/DE60308403T2/de not_active Expired - Fee Related
- 2003-10-06 JP JP2004542618A patent/JP2006504722A/ja active Pending
- 2003-10-06 MX MXPA05003625A patent/MXPA05003625A/es not_active Application Discontinuation
- 2003-10-06 CA CA002500906A patent/CA2500906A1/en not_active Abandoned
- 2003-10-06 US US10/530,566 patent/US20060058260A1/en not_active Abandoned
- 2003-10-06 CN CNA2003801011501A patent/CN1703225A/zh active Pending
- 2003-10-06 AU AU2003274306A patent/AU2003274306B2/en not_active Ceased
- 2003-10-06 KR KR1020057006138A patent/KR20050055758A/ko not_active Withdrawn
- 2003-10-06 WO PCT/GB2003/004328 patent/WO2004032939A1/en not_active Ceased
- 2003-10-06 BR BR0315087-9A patent/BR0315087A/pt not_active Application Discontinuation
- 2003-10-06 EP EP03758296A patent/EP1562610B1/en not_active Expired - Lifetime
- 2003-10-06 AT AT03758296T patent/ATE339209T1/de not_active IP Right Cessation
-
2005
- 2005-03-30 NO NO20051601A patent/NO20051601L/no unknown
- 2005-04-05 ZA ZA200502759A patent/ZA200502759B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA05003625A (es) | 2005-06-03 |
| CN1703225A (zh) | 2005-11-30 |
| EP1562610B1 (en) | 2006-09-13 |
| ZA200502759B (en) | 2006-06-28 |
| US20060058260A1 (en) | 2006-03-16 |
| AU2003274306B2 (en) | 2007-02-08 |
| CA2500906A1 (en) | 2004-04-22 |
| DE60308403T2 (de) | 2007-09-06 |
| DE60308403D1 (de) | 2006-10-26 |
| JP2006504722A (ja) | 2006-02-09 |
| EP1562610A1 (en) | 2005-08-17 |
| GB0223379D0 (en) | 2002-11-13 |
| ATE339209T1 (de) | 2006-10-15 |
| BR0315087A (pt) | 2005-08-16 |
| WO2004032939A1 (en) | 2004-04-22 |
| KR20050055758A (ko) | 2005-06-13 |
| AU2003274306A1 (en) | 2004-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1551409T3 (da) | Anvendelse af quinazolinderivatet ZD6474 kombineret med gemcitabin og eventuelt ioniserende stråling ved behandling af cancer | |
| NO20082567L (no) | Kombinasjon av ZD6474 og pemetrexed | |
| MX2007003505A (es) | Combinacion que comprende zd6474 e imatinib. | |
| MX2007003506A (es) | Terapia de combinacion de cancer que comprende azd2171 e imatinib. | |
| CY1111482T1 (el) | Συνδυασμος azd2171 και πεμετρεξεδης | |
| MXPA05008583A (es) | Terapia de combinacion de zd6474 con 5-fu y/o cpt-11. | |
| DK1653964T3 (da) | Cancerkombinationsterapi omfattende AZD2171 og ZD1839 | |
| NO20064755L (no) | Kombinasjonsterapi | |
| NO20056171L (no) | Kombinasjonsterapi | |
| NO20064754L (no) | Kombinasjonsterapi | |
| WO2007003933A3 (en) | Combination therapy of cancer with azd2171 and gemcitabine | |
| NO20051601L (no) | Kombinasjonsterapi med gemcitabin og zd6126 |